文献速递类风湿关节炎

多特异性抗瓜氨酸化蛋白抗体以时间依赖方式改善胶原抗体诱导性关节炎

Anti-Citrullinated Protein Antibodies With Multiple Specificities Ameliorate Collagen Antibody-Induced Arthritis in a Time-Dependent Manner.
PubMed 文献 · Arthritis Rheumatol · 2023-11-27

研究从一名类风湿关节炎患者浆母细胞抗体库中表达抗瓜氨酸化蛋白抗体(ACPAs),在抗原阵列和酶联免疫吸附试验中分析其自身抗原特异性,并在胶原抗体诱导性关节炎(CAIA)小鼠模型中测试其中9种ACPAs的效果。重组ACPAs优先以高亲和力(纳摩尔级)结合瓜氨酸化自身抗原(主要为组蛋白和纤维蛋白原)及自身瓜氨酸化肽酰精氨酸脱亚胺酶4(PAD4);在CAIA小鼠中,注射重组ACPAs较同型对照抗体显著降低爪厚度和关节炎严重度(P ≤ 0.001),骨侵蚀、滑膜炎和软骨损伤也显著减轻(P ≤ 0.01),且该改善在所有测试的ACPAs中均可见,与cit-PAD4和cit-纤维蛋白原特异性无关;在CAIA早期阶段注射ACPAs的疾病改善比在后期阶段更明显。结论认为重组患者来源ACPAs改善了CAIA,其抗炎作用更偏向预防而非治疗,提示ACPAs在关节炎中可能具有保护作用。

要点

  • 重组患者来源ACPAs在CAIA小鼠中显著减轻爪厚度和关节炎严重度(P ≤ 0.001)。
  • 骨侵蚀、滑膜炎和软骨损伤也显著减轻(P ≤ 0.01)。
  • 疾病改善在CAIA早期阶段注射时比后期阶段更明显。

核心结论

  • 重组患者来源ACPAs改善了CAIA,其抗炎作用更偏向预防而非治疗,提示ACPAs在关节炎中可能具有保护作用。

研究设计与样本

  • 研究从一名类风湿关节炎患者的浆母细胞抗体库中表达ACPAs,在抗原阵列和酶联免疫吸附试验中分析其自身抗原特异性,用生物层干涉术估计结合亲和力,并在CAIA小鼠模型中测试9种选定的ACPAs以评估其对关节炎症的影响。

主要发现

  • 重组ACPAs优先以高亲和力(纳摩尔级)结合瓜氨酸化自身抗原(主要为组蛋白和纤维蛋白原)及自身瓜氨酸化PAD4。
  • 在CAIA小鼠中,注射重组ACPAs较同型对照抗体显著降低爪厚度和关节炎严重度(P ≤ 0.001)。
  • 骨侵蚀、滑膜炎和软骨损伤也显著减轻(P ≤ 0.01)。
  • 该CAIA改善在所有测试的ACPAs中均可见,且与cit-PAD4和cit-纤维蛋白原特异性无关。
  • 当在CAIA早期阶段而非模型后期阶段注射ACPAs时,疾病改善更明显。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anti-citrullinated protein antibodies (ACPAs) are highly specific for rheumatoid arthritis (RA) and have long been regarded as pathogenic. Despite substantial in vitro evidence supporting this claim, reports investigating the proinflammatory effects of ACPAs in animal models of arthritis are rare and include mixed results. Here, we sequenced the plasmablast antibody repertoire of a patient with RA and functionally characterized the encoded ACPAs. METHODS: We expressed ACPAs from the antibody repertoire of a patient with RA and characterized their autoantigen specificities on antigen arrays and enzyme-linked immunosorbent assays. Binding affinities were estimated by bio-layer interferometry. Select ACPAs (n = 9) were tested in the collagen antibody-induced arthritis (CAIA) mouse model to evaluate their effects on joint inflammation. RESULTS: Recombinant ACPAs bound preferentially and with high affinity (nanomolar range) to citrullinated (cit) autoantigens (primarily histones and fibrinogen) and to auto-cit peptidylarginine deiminase 4 (PAD4). ACPAs were grouped for in vivo testing based on their predominant cit-antigen specificities. Unexpectedly, injections of recombinant ACPAs significantly reduced paw thickness and arthritis severity in CAIA mice as compared with isotype-matched control antibodies (P ≤ 0.001). Bone erosion, synovitis, and cartilage damage were also significantly reduced (P ≤ 0.01). This amelioration of CAIA was observed for all the ACPAs tested and was independent of cit-PAD4 and cit-fibrinogen specificities. Furthermore, disease amelioration was more prominent when ACPAs were injected at earlier stages of CAIA than at later phases of the model. CONCLUSION: Recombinant patient-derived ACPAs ameliorated CAIA. Their antiinflammatory effects were more preventive than therapeutic. This study highlights a potential protective role for ACPAs in arthritis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Gomez AM, Brewer RC, Moon JS, et al. Anti-Citrullinated Protein Antibodies With Multiple Specificities Ameliorate Collagen Antibody-Induced Arthritis in a Time-Dependent Manner. Arthritis Rheumatol. 2023. PMID: 37610274. doi:10.1002/art.42679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。